NOV 08, 2018 9:00 AM PST

Influenza 2018-2019: Are you ready?

Sponsored by: DiaSorin Molecular LLC
Speaker

Abstract

DATE: November 8, 2018
TIME:  9:00AM PST

Annual epidemics of influenza place a substantial burden on the health of people in the United States. CDC estimates that influenza has resulted in between 9.2 million and 35.6 million illnesses, between 140,000 and 710,000 hospitalizations, and between 12,000 and 56,000 deaths annually since 2010.

The cornerstone of influenza prevention is routine annual influenza vaccination, which is recommended for all persons aged ≥6 months who do not have contraindications. Multiple different vaccine types are available, including inactivated, live attenuated, and recombinant vaccines, as well as high dose and adjuvanted inactivated versions.

The majority of currently circulating influenza viruses are susceptible to the neuraminidase inhibitor antiviral medications—oseltamivir, zanamivir and peramivir. Antiviral treatment with a neuraminidase inhibitor is recommended as early as possible for patients with confirmed or suspected influenza who have severe, complicated, or progressive illness; who require hospitalization; or who are at increased risk for influenza-related complications.

Appropriate treatment of patients with influenza depends on accurate and timely diagnosis, and early diagnosis can reduce the inappropriate use of antibiotics and provide the option of using antiviral therapy. Diagnostic tests available for influenza include viral culture, serology, rapid antigen testing, reverse transcription PCR, immunofluorescence assays, and rapid molecular assays. Molecular assays are increasingly becoming the diagnostic tests of choice.

 

Learning Objectives:

  • Describe the epidemiology and clinical impact of seasonal influenza
  • Understand strategies for prevention of influenza including current vaccine recommendations
  • Recognize the value of diagnostic testing including advantages and disadvantages of different assay types

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
JUL 28, 2022 6:00 AM PDT
JUL 28, 2022 6:00 AM PDT
Date: July 28, 2022 Time: 6:00am (PDT), 9:00am (EDT) Hepatitis B and C continues to be a leading cause of global morbidity and mortality, resulting in 1.1 million deaths and 3 million new in...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
NOV 08, 2018 9:00 AM PST

Influenza 2018-2019: Are you ready?

Sponsored by: DiaSorin Molecular LLC


Show Resources
Loading Comments...
Show Resources